Fingolimod (CAS 162359-55-9)
Alternate Names:
Fingolimodum
CAS Number:
162359-55-9
Molecular Weight:
307.50
Molecular Formula:
C19H33NO2
Supplemental Information:
This is as a Dangerous Good for transport and may be subject to additional shipping charges.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
QUICK LINKS
Ordering Information
Description
Technical Information
Safety Information
SDS & Certificate of Analysis
Fingolimod (CAS 162359-55-9) References
- Fingolimod provides long-term protection in rodent models of cerebral ischemia. | Wei, Y., et al. 2011. Ann Neurol. 69: 119-29. PMID: 21280082
- Fingolimod administration improves neurological functions of mice with subarachnoid hemorrhage. | Wang, Y., et al. 2020. Neurosci Lett. 736: 135250. PMID: 32673690
- Fingolimod reduces salivary infiltrates and increases salivary secretion in a murine Sjögren's model. | Cohen, PL. and McCulloch, A. 2020. J Autoimmun. 115: 102549. PMID: 33059968
- The effect of fingolimod on regulatory T cells in a mouse model of brain ischaemia. | Malone, K., et al. 2021. J Neuroinflammation. 18: 37. PMID: 33516262
- Fingolimod attenuates gait deficits in mice subjected to experimental autoimmune encephalomyelitis. | Kasheke, GDS., et al. 2022. J Neuroimmunol. 370: 577926. PMID: 35863299
- Fingolimod Does Not Reduce Infarction After Focal Cerebral Ischemia in Mice During Active or Inactive Circadian Phases. | Mandeville, ET., et al. 2022. Stroke. 53: 3741-3750. PMID: 36252110
- Fingolimod attenuates ovalbumin-induced airway inflammation via inhibiting MAPK/ERK signaling in mice. | Makled, MN. and El-Sheakh, AR. 2023. J Biochem Mol Toxicol. 37: e23266. PMID: 36468814
- CDX-modified chitosan nanoparticles remarkably reduce therapeutic dose of fingolimod in the EAE model of mice. | Sepasi, T., et al. 2023. Int J Pharm. 636: 122815. PMID: 36907279
- Fingolimod mitigates memory loss in a mouse model of Gulf War Illness amid decreasing the activation of microglia, protein kinase R, and NFκB. | Carreras, I., et al. 2023. Neurotoxicology. 96: 197-206. PMID: 37160207
- Ameliorative effects of Fingolimod (FTY720) on microglial activation and psychosis-related behavior in short term cuprizone exposed mice. | Li, S., et al. 2023. Mol Brain. 16: 59. PMID: 37438826
Inhibitor of:
BBS9, BTN3A1, C11orf51, C18orf19, C2, Cd1d2, Cd59b, Ceramide Kinase, DRP2, IgG, IgG κ light chain, IL-2, LRCH4, MS4A4A, NFATc1, NG2, Olfr608, Olfr610, OLIG2, PMP22, saposin, SGS3, Skint11, SMPD5, SPT1, T-cell receptor Vδ 1, TAFA2, Trav12-1, WC1, and XCR1 (X-C motif chemokine receptor 1).Activator of:
ASAH3, BSMAP, CD3-ε, DIRAS1, Gα i-2, GIMAP9, IFI-203, IgG λ light chain, IgM, Influenza A m1, Lingo-1, MAP-1A, MFSD2B, MORN4, MOSPD2, NKG2-B, NKG2-D, periaxin, PSAPL1, SMS1, SphK2, Syntaxin 1, TMEM49, TREM-2b, and Trp53i11.Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Fingolimod, 10 mg | sc-507334 | 10 mg | $160.00 |